Kolexia
Hiriart Jean-Baptiste Gastro-entérologie
Hiriart Jean-Baptiste
Gastro-entérologie
Hôpital Haut-lévêque
Pessac, France
96 Activités
19 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Cirrhose du foie Stéatose hépatique non alcoolique Maladies du foie Stéatose hépatique Carcinome hépatocellulaire Syndrome métabolique X Carcinomes Tumeurs du foie

Collaborateurs

Voir plus
De Ledinghen Victor
De Ledinghen Victor
Hôpital Haut-lévêque, Pessac, France
Foucher Juliette
Foucher Juliette
Hôpital Haut-lévêque, Pessac, France
Vergniol Julien
Vergniol Julien
Msp Bordeaux Bagatelle, Talence, France
Chermak Faiza
Chermak Faiza
Hôpital Haut-lévêque, Pessac, France

Industries

Voir plus
P\S\L Group Services
168 collaboration(s)
Dernière en 2023
IQVIA
118 collaboration(s)
Dernière en 2023
B3TSI
83 collaboration(s)
Dernière en 2023
A+A
40 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Rechallenge de l’immunothérapie après toxicités sévères : expérience d’une RCP immunoTox
Journées dermatologiques de Paris 2023   01 décembre 2023
PVNIM: Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.
Essai Clinique (CHU Bordeaux)   19 juillet 2023
Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society   28 juin 2023
Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study.
Clinics and research in hepatology and gastroenterology   21 juin 2023
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.
JHEP reports : innovation in hepatology   03 janvier 2023
REACH-2: Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib
Essai Clinique (Lilly)   22 décembre 2022
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.
Liver international : official journal of the International Association for the Study of the Liver   25 août 2022
Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence.
Cancer gene therapy   07 mars 2022
Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods.
Alimentary pharmacology & therapeutics   03 janvier 2022
Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.
Liver international : official journal of the International Association for the Study of the Liver   12 novembre 2021